ViroStatics Competitors and Similar CompaniesClear all

FORMA Therapeutics's competitors and similar companies include Halozyme Therapeutics and Ablynx.
FORMA Therapeutics
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
Ablynx
Ablynx
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
Founding Date
Founding Date
2008
Founding Date
1998
Founding Date
2001
Type
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Watertown, US HQ
Locations
San Diego, US HQ
Locations
Gent, BE HQ
Employees
Employees
77
Employees
373157% increase
Employees
1252% decrease
Valuation ($)
Valuation ($)
998.7 m
Valuation ($)
6.4 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$1.4b (FY, 2025)
Revenue (est.)
€85.2m (FY, 2016)
Net income
Net income
($173m) (FY, 2021)
Net income
$316.9m (FY, 2025)
Net income
(€1.1m) (FY, 2016)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
43 (FY, 2020)
Patents (US)
50 (Q2, 2017)

Funding

Total funding raised
Total funding raised
$ 142.5m
Total funding raised
$ 171.9m
Total funding raised
$ 498.8m
For sources of this data, please see the company profile

View Company Profiles

Halozyme Therapeutics
HQ
San Diego, US
Employees
373

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.

View company
Ablynx
HQ
Gent, BE

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.

View company